Jazz Pharmaceuticals plc (JAZZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Jazz Pharmaceuticals plc maintains a healthy position.
The total current assets of the company are valued at $3263921000.
This represents a growth rate of 25.240% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $1206310000, exhibiting a growth rate of 36.850% year-on-year.
The receivables, another significant portion of the current assets, are valued at $705794000.
The year-on-year growth rate for receivables is 8.335%.
The inventory, which forms a critical part of the assets, is valued at $597039000.
This represents a healthy year-on-year growth of -16.388%
On the liabilities side, the company's current liabilities total $1536692000.
This reflects a growth rate of 64.670% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
1206.31
881.48
591.45
1057.77
637.34
309.62
Receavebles
705.79
651.49
563.36
396.49
355.99
263.84
Inventory
597.04
714.06
1072.72
95.40
78.61
52.96
Other
334.78
267.19
252.39
152.49
78.89
67.57
Total Current Assets
3263.92
2606.14
2611.33
2839.57
1630.27
1234.01
Acc Payable
102.75
90.76
100.30
26.95
47.55
40.60
Short Term Debt
624.40
31.00
31.00
246.32
33.39
33.39
Other Current Liab
774.47
810.97
675.91
377.93
278.84
266.08
Current Liabilities
1536.69
933.19
809.30
653.75
364.49
345.49
Capital Structure
When examining the capital structure of Jazz Pharmaceuticals plc, it is clear that the company manages a robust portfolio.
These earnings represent the profits that Jazz Pharmaceuticals plc has chosen to reinvest in the business rather than distribute as dividends.
